📰 Registration Pathway News
Registration Pathway News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Registration Pathway. Real-time updates on events, politics, business and more.
October 6, 2023
DEA extends COVID-19 era rules allowing healthcare providers to prescribe certain controlled substances via telehealth through 2024, to give time to patients wh
May 19, 2022
On-track to activate first US clinical trial sites in on-going pivotal phase III global registration study, NANORAY-312, in locally advanced head and neck squamous cell carcinoma (LA-HNSCC) in Q3
May 18, 2022
On-track to activate first US clinical trial sites in on-going pivotal phase III global registration study, NANORAY-312, in locally advanced head and neck squamous cell carcinoma (LA-HNSCC) in Q3
May 18, 2022
18.05.2022 - Regulatory News: NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the Company), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced operational ... Seite 1